The incidence of nonmelanoma cutaneous head and neck malignancies is increasing worldwide.
Discussion
The trigeminal (V) and facial (VII) nerves are the most common cranial nerves to be affected by PNS, 5 and disease may progress slowly over a period of 6 months to 2 years before a diagnosis is made, which significantly affects prognosis. 6 Symptoms of trigeminal nerve PNS include numbness, pain, formication, and paresthesia in the distribution of the affected branch. 7 The orbit can also be accessed through spread along the ophthalmic nerve (V1), and patients may present with diplopia and/or visual impairment. 8 Facial nerve involvement is characterized by a slowly progressive palsy of the affected hemiface. 7, 9 The anatomic extent of PNS seen on MRI has a previously described zonal classification and allows for surgical planning.
9,10 Zone 1 boundaries are: V1 to the superior orbital fissure; V2 to the external aperture of the foramen rotundum; V3 to the external aperture of the foramen ovale; and VII to the external aperture of the stylomastoid foramen. Zone 2 boundaries are: V1, V2, V3 from zone 1 to the gasserian ganglion cistern; and VII from zone 1 to the lateral end of the internal auditory canal, with inclusion of the geniculate ganglion and the labyrinthine segment. Finally, zone 3 encompasses all nerves from the ganglion into the cisterns or into the brainstem.
The goal of surgical resection of the disease to a margin clear of disease is to prevent additional retrograde spread to the brainstem. In our experience, patients are classified as having inoperable disease if the disease extends proximally to the gasserian (V) or geniculate (VII) ganglion (zone 3).
A retrospective review from our department of 21 patients with clinical PNS from cutaneous SCC of the head and neck who underwent surgical resection to the gasserian or geniculate ganglion demonstrated a 5-year disease-specific survival rate for zone I and II disease of 80% and 55%, respectively, supporting our experience that surgical excision of the disease to the ganglion improves survival without significant additional morbidity. V2 to right V3) can occur. Current practice for postoperative radiotherapy includes irradiation of central disease, as previously described, but for the cutaneous distribution of the particular cranial nerve branch to the facial midline only. 8, 11 Within our subset, patients 1, 3, 4, and 6 did not have evidence of a second primary on the contralateral hemiface that potentially could have been responsible for the clinical findings. Patients 1, 3, and 4 had primary lesions occur on the nose, close to the midline, whereas patient 6 had multiple recurrences at the midline margin of the radiotherapy volume. We propose that the disease extension occurred across the facial midline by local spread from the cutaneous peripheral branches of the affected cranial nerve and those of the contralateral side. Therefore, these patients could have potentially benefited from extending the radiotherapy volumes across the midline 2 to 3 cm to further prevent contralateral cutaneous spread.
At the time of postoperative radiotherapy, microscopic PNS across the midline to the contralateral peripheral trigeminal or facial nerve branch may have already occurred, and the standard radiotherapy volume used would have failed to sterilize that affected area. Extension of the radiotherapy volumes across the midline could potentially treat any microscopic PNS on the contralateral side, thus preventing any further spread. An exception was noted with patient 2, given that the ipsilateral disease was in the right V2 area and likely developed into a separate primary lesion with associated PNS of V3 and VII on the contralateral side; thus, this patient would not likely have benefited from extended volumes of postoperative radiotherapy. Additionally, extended volumes would not likely have benefited patient 5 because, unfortunately, his disease spread centrally.
For postoperative radiotherapy planning, detailed knowledge of the anatomy of the trigeminal and facial nerves is imperative to accurately include the cutaneous distribution of particular peripheral branches and follow the course of the nerve trunk to the desired level. The anatomic course of the trigeminal nerve, from the brainstem through the skull base to the peripheral branches, is well described. 12, 13 However, the precise boundaries of the areas of sensation supplied by the ophthalmic, maxillary, and mandibular branches and the interindividual variation present in the general population are not known. The anatomy of the facial nerve trunk and its five subsequent branches is also well known. 13 Interconnections between the trigeminal and facial nerves on each side exist that could potentiate PNS from an affected branch to another on the same side.
14 At present, no evidence exists that describes, in detail, the anatomic relationship of the terminal cutaneous branches of the trigeminal and facial nerves of each hemiface and whether they interconnect or overlap slightly along the facial midline. During radiotherapy planning, the cutaneous area to be irradiated is based on the boundaries described in this report but is ultimately at the discretion of the treating radiation oncologist.
The primary aim of this report was to provide evidence in support of an argument to extend postoperative radiotherapy volumes in this particular patient population. Previously, with older radiation planning and delivery, this was not practical because of the inherent increased morbidity that was associated with extending the radiotherapy volume across midline. Nowadays, these patients are treated postoperatively with intensity-modulated radiotherapy, which is an external beam radiotherapy that allows the radiation dose to conform more closely to the shape of the tumor by changing the intensity of the radiation beam. With more sophisticated radiotherapy like intensitymodulated radiotherapy, the treating oncologist may be able to extend the postoperative radiotherapy volumes without a significant increase in treatment morbidity.
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